Select Committee · Science and Technology Committee (Commons)
Life sciences investment
Status: Open
Opened: 16 Sep 2025
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 16 Sep 2025 |
Life sciences investment
Ben Lucas · The Association of the British Pharmaceutical Industry (ABPI),
Dr Richard Torbett · Association of the British Pharmaceutical Industry (ABPI),
Dr Zubir Ahmed MP · Department of Health and Social Care (DHSC),
Lord Patrick Vallance · DSIT,
Rosalind Campion · Office for Life Sciences,
Tom Keith-Roach · AstraZeneca plc
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Ben Lucas · Board Member | The Association of the British Pharmaceutical Industry (ABPI) | 1 |
| Dr Richard Torbett · CEO | Association of the British Pharmaceutical Industry (ABPI) | 1 |
| Dr Zubir Ahmed MP · Parliamentary Under-Secretary of State | Department of Health and Social Care (DHSC) | 1 |
| Lord Patrick Vallance · Minister for Science, Research and Innovation | DSIT | 1 |
| Rosalind Campion · Director | Office for Life Sciences | 1 |
| Tom Keith-Roach · UK Country President | AstraZeneca plc | 1 |